Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-26

Clinical Trial Update: Relative Bioavailability Study for GSK1278863A [Phase 1]

View source ↗

Summary

Completion of a Phase 1 relative bioavailability study of GSK1278863A is reported, indicating the trial has reached completion with PK-focused data; no efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GSK1278863A (GSK1278863A)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anaemia | Phase 1 | Status: COMPLETED